SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007379
Filing Date
2016-08-04
Accepted
2016-08-04 16:01:14
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20160630x10q.htm 10-Q 1191738
2 EX-31.1 glyc-20160630ex3118164de.htm EX-31.1 18335
3 EX-31.2 glyc-20160630ex3129f8509.htm EX-31.2 17386
4 EX-32.1 glyc-20160630ex321fd196e.htm EX-32.1 10218
  Complete submission text file 0001558370-16-007379.txt   4506268

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20160630.xml EX-101.INS 1003280
6 EX-101.SCH glyc-20160630.xsd EX-101.SCH 27861
7 EX-101.CAL glyc-20160630_cal.xml EX-101.CAL 31116
8 EX-101.DEF glyc-20160630_def.xml EX-101.DEF 95812
9 EX-101.LAB glyc-20160630_lab.xml EX-101.LAB 255523
10 EX-101.PRE glyc-20160630_pre.xml EX-101.PRE 198946
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 161807278
SIC: 2834 Pharmaceutical Preparations